Related Experiment Video
Updated: Jun 23, 2026

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
Published on: June 28, 2013
Cryo-EM structures of PP2A:B55-FAM122A and PP2A:B55-ARPP19
Sathish K R Padi1, Margaret R Vos2, Rachel J Godek2
1Department of Molecular Biology and Biophysics, University of Connecticut Health Center, Farmington, CT, USA.
Cell cycle progression relies on protein phosphorylation. This study reveals how intrinsically disordered proteins ARPP19 and FAM122A inhibit the phosphatase PP2A:B55, crucial for mitotic exit, through distinct binding mechanisms.
Area of Science:
- Molecular biology
- Structural biology
- Biochemistry
Background:
- Cell cycle progression is regulated by dynamic phosphorylation events.
- Mitotic exit is primarily controlled by phosphatases, particularly PP2A:B55.
- Inhibition of PP2A:B55 by ARPP19 and FAM122A is critical for successful mitosis, but the mechanism remains unclear.
Purpose of the Study:
- To elucidate the molecular mechanisms by which ARPP19 and FAM122A inhibit PP2A:B55.
- To determine the structural basis of PP2A:B55 inhibition by these intrinsically disordered proteins.
Main Methods:
- Single-particle cryo-electron microscopy (cryo-EM) to determine structures of PP2A:B55 bound to inhibitors.
- Nuclear Magnetic Resonance (NMR) spectroscopy to study protein interactions.
- Biophysical and biochemical assays to characterize binding and inhibition.
Main Results:
- The study determined the cryo-EM structures of PP2A:B55 in complex with phosphorylated ARPP19 and FAM122A.
- Both ARPP19 and FAM122A bind to PP2A:B55 through distinct mechanisms, utilizing multiple binding sites on the B55 subunit.
- NMR studies corroborated the distinct binding modes observed in the structural analysis.
Conclusions:
- ARPP19 and FAM122A inhibit PP2A:B55 through unique molecular interactions.
- The findings provide a structural and mechanistic understanding of PP2A:B55 regulation by intrinsically disordered proteins.
- This research offers a molecular roadmap for developing therapeutics targeting PP2A:B55-related diseases.
More Related Videos
13:34Production, Crystallization and Structure Determination of C. difficile PPEP-1 via Microseeding and Zinc-SAD
Published on: December 30, 2016
11:45The CryoAPEX Method for Electron Microscopy Analysis of Membrane Protein Localization Within Ultrastructurally-Preserved Cells
Published on: February 27, 2020